We have shared our 2023 Winter HONEUR Newsletter. This edition features:

• 23 HONEUR data partners, with CHU Nice and Policlinico di Milano as our newest members:

  CHU de Nice
  The hematology department of CHU Nice specializes in the management of blood and lymph node disorders, including cancers. It develops recourse activities such as allogenic and autologous hemapoietic stem cell transplantation, intensive chemotherapy, and clinical research, allowing for access to innovative treatments.

  

   

  Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
  The Hematology department at Ospedale Maggiore Policlinico of Milan specialises in the clinical management of benign and malignant hematology disorders. Within the largest public research hospital in Italy, the hematology department performs basic, translational and clinical research in myeloma, myeloid and lymphoid malignancies, with special focus on disease pathogenesis and genomic predictors of clinical outcomes.

  

• details about the upcoming HONEUR Forum and HONEUR Board elections on 20-21 March 2024 in Rome, Italy.

• ongoing and planned evidence-generation projects, with a focus on our HONEUR Landmark Study